Heart transplantation is the final therapeutic option for patients with end-stage heart failure who are no longer responding to medications, devices (like CRT or ICD), or other surgical options. Before listing a patient for transplant, a thorough pre-transplant evaluation is essential to determine suitability, optimize management, and anticipate post-transplant challenges.
One of the most critical tests in this evaluation is the Right Heart Catheterization (RHC) β also known as Pulmonary Artery Catheterization.
RHC is an invasive diagnostic procedure where a thin, flexible catheter is inserted (usually through the neck or groin) into a central vein and guided into the right side of the heart and pulmonary artery. It allows direct measurement of pressures and flows inside the heart and lungs.
Unlike echocardiography or CT scans, which estimate pressures indirectly, RHC gives real-time, direct measurements of:
Right atrial pressure (RAP)
Pulmonary artery pressure (PAP)
Pulmonary capillary wedge pressure (PCWP)
Cardiac output/index (CO/CI)
Systemic and pulmonary vascular resistance
These values help assess severity and type of heart failure, and determine how well the heart is pumping blood to the lungs and rest of the body.
One of the major contraindications for heart transplantation is irreversible pulmonary hypertension.
If pulmonary vascular resistance (PVR) is too high and not reversible, the donor heart may fail immediately after transplantation due to the strain on its right ventricle.
RHC helps differentiate between passive (left-heart related) and fixed (vascular remodeling) pulmonary hypertension.
If PH is reversible with vasodilators or inotropes (tested during RHC), the patient may still be a transplant candidate.
Right heart failure is a serious complication after transplant. If RHC shows poor right ventricular output or high right-sided filling pressures, doctors may:
Delay transplant and optimize medical therapy
Consider temporary mechanical support (ECMO, RVAD)
Plan intra/post-operative support strategies during transplant
Based on RHC findings, doctors can fine-tune:
Diuretics for fluid overload
Vasodilators or inotropes for low cardiac output
Pulmonary vasodilators if PH is present
This ensures the patient is in optimal condition at the time of transplant.
In most transplant programs globally (including India), right heart cath is a mandatory component of transplant listing protocols as per ISHLT (International Society for Heart & Lung Transplantation).
RHC data is needed for listing status, donor-recipient matching, and for surgical planning.
Sometimes, patients with normal-looking left ventricular function on echo may still have:
High filling pressures
Elevated PVR
Low cardiac output
RHC uncovers these hidden hemodynamic derangements, preventing post-op surprises and helping select the right timing for transplant.
| Purpose | Why It Matters |
|---|---|
| Measure Heart Pressures | Accurate, direct assessment of heart & lung hemodynamics |
| Detect Pulmonary Hypertension | Identify and assess reversibility of PVR |
| Assess Right Heart Function | Predict need for mechanical support |
| Guide Pre-Transplant Optimization | Tailor medications and interventions |
| Fulfill International Listing Criteria | Required for ethical, evidence-based transplant decisions |
βRight Heart Catheterization is not just a formalityβitβs the compass that guides us through the complex decision-making in heart transplantation. Without it, weβre flying blind.β
β Dr. Srinath Vijayasekharan, Cardiothoracic Surgeon, Rela Hospital
βIt helps us protect the donor heart, tailor the treatment, and ensure our patients not only survive, but thrive after transplant.β
β Dr. Senthil Kumar, Cardiothoracic Surgeon, Rela Hospital
A dedicated cardiac cath lab with real-time monitoring
By an experienced multidisciplinary transplant team
With safety protocols and minimal complication risk
π Right Heart Cath Study at Rela Hospital
π¨ββοΈ Under the care of Dr. Srinath Vijayasekharan & Dr. Senthil Kumar
π§ͺ Precision. Safety. Life-saving data.